secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bluejay Diagnostics, Inc. (BJDX)
CIK:        0001704287
Form:       8-K
Filed at:   2025-06-20T23:59:59+00:00
Accession:  0001213900-25-055724
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Bluejay Diagnostics shareholders approve reverse stock split of up to 1-for-20
------------------------------------------------------------------------------

- Re-elected directors Chase, N. Dey, S. Dey, Wurth, Zeidman to 2026 term.
- Approved reverse stock split at 1-for-2 to 1-for-20 ratio; board may implement within one year.
- Approved additional reverse split (same ratio) contingent on first split being executed.
- Ratified Wolf & Company as independent auditor for FY 2025.
- Record date May 15, 2025; 616,134 shares voted from 1,494,182 outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1704287/000121390025055724/0001213900-25-055724-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1704287/000121390025055724/ea0246255-8k_bluejay.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-055724

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer